期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 287, 期 48, 页码 40629-40640出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.418442
关键词
-
资金
- National Institutes of Health [AG033138, AG020206]
- NIA
The presence of neuritic plaques containing aggregated amyloid-beta (A beta) peptides in the brain parenchyma is a pathological hallmark of Alzheimer disease (AD). A beta is generated by sequential cleavage of the amyloid beta precursor protein (APP) by beta- and gamma-secretase, respectively. As APP processing to A beta requires transport through the secretory pathway, trafficking of the substrate and access to the secretases are key factors that can influence A beta production (Thinakaran, G., and Koo, E. H. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619). Here, we report that retention in endoplasmic reticulum 1 (RER1) associates with gamma-secretase in early secretory compartments and regulates the intracellular trafficking of gamma-secretase. RER1 overexpression decreases both gamma-secretase localization on the cell surface and A beta secretion and conversely RER1 knockdown increases the level of cell surface gamma-secretase and increases A beta secretion. Furthermore, we find that increased RER1 levels decrease mature APP and increase immature APP, resulting in less surface accumulation of APP. These data show that RER1 influences the trafficking and localization of both gamma-secretase and APP, thereby regulating the production and secretion of A beta peptides.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据